pediatric cerebrovascular disease
Conditions
Interventions
dexmedetomidine group:dexmedetomidine
propofol group:propofol
Sponsors
Department of Anesthesiology, First Hospital of Soochow University
Eligibility
Sex/Gender
Male
Age
6 Years to 15 Years
Inclusion criteria
Inclusion criteria: Children between the ages of 3 and 15 years with ASA classification17 of I or II were eligible for inclusion in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria were known allergy to a-2 agonists, obesity, ASA classification III or more, cardiac abnormalities, craniofacial anomaly, respiratory problems (pneumonia, asthma, bronchitis and severe obstructive sleep apnea), Glasgow Coma Scale (GCS)<15, intracranial hypertension and uncontrolled epilepsy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemodynamic changes;adverse event; | — |
Countries
China
Contacts
Public ContactKe Peng
Outcome results
None listed